최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of inflammation, v.17 no.1, 2020년, pp.20 -
Yoon, Sae-Bom (Drug Discovery Platform Research Center, Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, 141 Gajeong-ro, Yuseong, Daejeon, 34114 Republic of Korea) , Lee, Chang Hoon (Drug Discovery Platform Research Center, Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, 141 Gajeong-ro, Yuseong, Daejeon, 34114 Republic of Korea) , Kim, Hyun Young (Drug Discovery Platform Research Center, Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, 141 Gajeong-ro, Yuseong, Daejeon, 34114 Republic of Korea) , Jeong, Daeyoung (Drug Discovery Platform Research Center, Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, 141 Gajeong-ro, Yuseong, Daejeon, 34114 Republic of Korea) , Jeon, Moon Kook (Drug Discovery Platform Research Center, Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, 141 Gajeong-ro, Yuseong, Daejeon, 34114 Republic of Korea) , Cho, Sun-A (Department of Laboratory Animal Medicine, Research Inst) , Kim, Kwangmi , Lee, Taeho , Yang, Jung Yoon , Gong, Young-Dae , Cho, Heeyeong
BackgroundAtopic dermatitis (eczema) is a type of inflammation of the skin, which presents with itchy, red, swollen, and cracked skin. The high global incidence of atopic dermatitis makes it one of the major skin diseases threatening public health. Sphingosylphosphorylcholine (SPC) and sphingosine-1...
1. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990?2015: a systematic analysis for the global burden of disease study 2015 Lancet 2016 288 1545 1602
2. Hannun YA Bell RM Functions of sphingolipids and sphingolipid breakdown products in cellular regulation Science. 1989 243 500 507 2643164
3. Cifone MG Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase J Exp Med 1994 180 1547 1552 7523573
4. Okazaki Hannun, Sphingomyelin turnover induced by vitamin D3 in HL-60 cells. Role in cell differentiation J Biol Chem 1989 264 19076 19080 2808413
5. Auge N Sphingomyelin metabolites in vascular cell signaling and atherogenesis Prog Lipid Res 2000 39 207 229 10799716
6. Murata Y Abnormal expression of sphingomyelin acylase in atopic dermatitis: an etiologic factor for ceramide deficiency? J Invest Dermatol 1996 106 1242 1249 8752664
7. Imokawa G Lipid abnormalities in atopic dermatitis J Am Acad Dermatol 2001 45 29 32
8. Okamoto R Sphingosylphosphorylcholine is upregulated in the stratum corneum of patients with atopic dermatitis J Lipid Res 2003 44 93 102 12518027
9. Chin TY Chueh SH Sphingosylphosphorylcholine stimulates mitogen-activated protein kinase via a Ca 2+ -dependent pathway Am J Phys 1998 275 C1255 C1263
10. Desai NN Spiegel S Sphingosylphosphorylcholine is a remarkably potent mitogen for a variety of cell lines Biochem Biophys Res Commun 1991 181 361 366 1958205
11. Hennings H Calcium regulation of growth and differentiation of mouse epidermal cells in culture Cell. 1980 19 245 254 6153576
12. Kwon YB Sphingosylphosphorylcholine-induced interleukin-6 production is mediated by protein kinase C and p42/44 extracellular signal-regulated kinase in human dermal fibroblasts J Dermatol Sci 2007 46 91 99 17321112
13. Zhu MJ Induction of connective tissue growth factor expression by sphingosylphosphorylcholine in cultured human skin fibroblasts Exp Dermatol 2005 14 509 514 15946238
14. Imokawa G Sphingosylphosphorylcholine is a potent inducer of intercellular adhesion molecule-1 expression in human keratinocytes J Investig Dermatol 1999 112 91 96 9886270
15. Wirring C Sphingosylphosphorylcholine is a proinflammory mediator in cerebral arteries J Cereb Blood Metab 2011 31 212 221
16. Lee HY Sphingosylphosphorylcholine stimulates CCL2 production from human umbilical vein endothelial cells J Immunol 2011 186 4347 4353 21368227
17. Imokawa G A possible mechanism underlying the ceramide deficiency in atopic dermatitis: expression of a deacylase enzyme that cleaves the N-acyl linkage of sphingomyelin and glucosylceramide J Dermatol Sci 2009 55 1 9 19443184
18. Jeon ES Sphingosylphosphorylcholine induces apoptosis of endothelial cells through reactive oxygen species-mediated activation of ERK J Cell Biochem 2007 100 1536 1547 17131361
19. Kye KC Signaling events during induction of plasminogen activator inhibitor-1 expression by sphingosylphosphorylcholine in cultured human dermal fibroblasts J Invest Dermatol. 2004 122 1365 1371 15175025
20. Xin C Sphingosylphosphorylcholine acts in an anti-inflammatory manner in renal mesangial cells by reducing interleukin-1beta-induced prostaglandin E2 formation J Lipid Res 2007 48 1985 1996 17592175
21. Kabarowski JH Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A Science. 2001 293 702 705 11474113
22. Ludwig MG Proton-sensing G-protein-coupled receptors Nature. 2003 425 93 98 12955148
23. Bektas M The G protein-coupled receptor GPR4 suppresses ERK activation in a ligand-independent manner Biochemistry. 2003 42 12181 12191 14567679
24. Mogi C Sphingosylphosphorylcholine antagonizes proton-sensing ovarian cancer G-protein-coupled receptor 1 (OGR1)-mediated inositol phosphate production and cAMP accumulation J Pharmacol Sci 2005 99 160 167 16210776
25. Xu Y Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1 Nat Cell Biol 2000 2 261 267 10806476
26. Murakami N G2A is a proton-sensing G-protein-coupled receptor antagonized by lysophosphatidylcholine J Biol Chem 2004 279 42484 42491 15280385
27. Lin P Ye RD The lysophospholipid receptor G2A activates a specific combination of G proteins and promotes apoptosis J Biol Chem 2003 278 14379 14386 12586833
28. Parrill AL Sphingosine 1-phosphate and lysophosphatidic acid receptors: agonist and antagonist binding and progress toward development of receptor-specific ligands Semin Cell Dev Biol 2004 15 467 476 15271292
29. Nixon GF The multi-functional role of sphingosylphosphorylcholine Prog Lipid Res 2008 47 62 75 18042469
30. Young-Dae G, et al.2, 4-disubstituted-5-aminocarbonyl-1, 3-thiazole derivatives for therapeutic agent of antiinflammatory disease, method thereof for preparation, therapeutic agent for antiinflammatory disease induced by SPC activity containing the same. U.S. Patent No. 7915405. 2011.
31. Jung K Adhesion molecules in atopic dermatitis: VCAM-1 and ICAM-1 expression is increased in healthy-appearing skin Allergy 1996 51 7 452 460 8863922
32. Reitamo S Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis J Allergy Clin Immunol 2002 109 547 555 11898005
33. Tsugunobu A Leukotriene B 4 mediates sphingosylphosphorylcholine-induced itch-associated responses in mouse skin J Invest Dermatol. 2009 129 2854 2860 19657356
34. Kleuser B Sphingolipids and inflammatory diseases of the skin Handb Exp Pharmacol 2013 216 355 372
35. Herzinger T Sphingosine-1-phosphate signaling and the skin Am J Clin Dermatol 2007 8 329 336 18039015
36. Japtok L Sphingosine-1-phosphate as signaling molecule in the skin Allergo J Int 2014 23 54 59 26120515
37. Sun L A new wound healing agent―sphingosylphosphorylcholine J Invest Dermatol. 1996 106 232 237 8601721
38. Piao YJ Involvement of urokinase-type plasminogen activator in sphingosylphosphorylcholine-induced angiogenesis Exp Dermatol 2005 14 356 362 15854129
39. Deshmane SL Monocyte chemoattractant protein-1 (MCP-1): an overview J Interf Cytokine Res 2009 29 313 326
40. Niu J Kolattukudy PE Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications Clin Sci 2009 117 95 109 19566488
41. Soria G Ben-Baruch A The inflammatory chemokines CCL2 and CCL5 in breast cancer Cancer Lett 2008 267 271 285 18439751
42. Shahrara S Inhibition of monocyte chemoattractant protein-1 ameliorates rat adjuvant-induced arthritis J Immunol 2008 180 3447 3456 18292571
43. Suarez-Farinas M Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis J Allergy Clin Immunol 2013 132 361 370 23777851
44. Pene J Interleukin 5 enhances interleukin 4-induced IgE production by normal human B cells. The role of soluble CD23 antigen Eur J Immunol 1988 18 929 935 3260186
45. Murakawa M Involvement of tumor necrosis factor (TNF)-alpha in phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced skin edema in mice Biochem Pharmacol 2006 71 1331 1336 16487490
46. Pail PB The role of kinin B 1 and B 2 receptors in the mouse model of oxazolone-induced atopic dermatitis Int Immunopharmacol 2019 72 62 73 30959373
47. Bradley PP Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker J Invest Dermatol. 1982 78 206 209 6276474
48. Liu FT IgE, mast cells, and eosinophils in atopic dermatitis Clinic Rev Allerg Immunol 2001 41 298 310
49. Silva AR Monocyte chemoattractant protein-1 and 5-lipoxygenase products recruit leukocytes in response to platelet-activating factor-like lipids in oxidized low-density lipoprotein J Immunol 2002 168 4112 4120 11937571
50. Lee K Treatment of dextran sulfate sodium-induced colitis with mucosa-associated lymphoid tissue lymphoma translocation 1 inhibitor MI-2 is associated with restoration of gut immune function and the microbiota Infect Immun 2018 86 12 e00091 e00018 30249750
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.